ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
The Global Market for Stem Cells Published on July 2014
Report Summary This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018. Use this report to: - Quantify and qualify the stem cell research market for prescription drug products. - Receive information about stem cell technology and its practical applications. - Understand how the regulatory environment, healthcare policies, demographics, and other factors directly affect the stem cell-related drug market. - Learn about the nature and structure of the stem cell industry along with profiles of the leading companies. Highlights - BCC Research projects that the global stem cell market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018. - The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018. - Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013. INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2018; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell-related drug market. The wider economic environment is also taken into account. The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market. REASONS FOR DOING THE STUDY Although products based on stem cells do not yet form an established market, unlike some other potential applications of bioscience, stem cell technology has already produced a number of significant products in important therapeutic areas. This is because the possibilities for successful stem cell therapy are almost beyond estimation, and the urgent need to develop this field is overriding the established, step-by-step approach to proceeding from basic science to practical applications. The potential
The Global Market for Stem Cells (From Issuu)
Page 1/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future. SCOPE OF REPORT This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved. MARKET ANALYSES AND FORECASTS Market figures are based on revenues at the manufacturer level and are projected at 2014-dollar value without attempting to predict the effect of inflation/deflation. Therapeutic categories quantified and forecast include cancer, CNS diseases, infections and cardiovascular. Major country markets in three regions'Americas, Europe and Asia'are analyzed and forecast, with a summary for the rest of the world. METHODOLOGY Both primary and secondary research methodologies were used in preparing this study. Primary research includes interviews with leading individuals in stem cell companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC Research. INTENDED AUDIENCE This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are operating. INFORMATION SOURCES Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also reviewed.
Table of Content TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 2 STUDY GOALS AND OBJECTIVES 2 REASONS FOR DOING THE STUDY 2
The Global Market for Stem Cells (From Issuu)
Page 2/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! SCOPE OF REPORT 2 MARKET ANALYSES AND FORECASTS 2 METHODOLOGY 3 INTENDED AUDIENCE 3 INFORMATION SOURCES 3 ANALYST'S CREDENTIALS 3 RELATED BCC RESEARCH REPORTS 3 BCC RESEARCH WEBSITE 3 DISCLAIMER 4 CHAPTER 2 SUMMARY 6 DEFINITIONS 6 APPLICATIONS 6 RESEARCH AND COMMERCIALIZATION 6 FUNDING 7 MARKET 7 SUMMARY TABLE GLOBAL STEM CELL MARKET AND FORECASTS, THROUGH 2018 ($ MILLIONS) 8 SUMMARY FIGURE GLOBAL STEM CELL MARKET AND FORECASTS, 2012-2018 ($ MILLIONS) 8 CHAPTER 3 OVERVIEW 10 CELLS 10 STEM CELLS 10 FIGURE 1 EARLY DEVELOPMENT OF EMBRYO 10 INDUCED PLURIPOTENT STEM CELLS 13 hpSCS 14 THE CANCER PROBLEM 15 CANCER STEM CELLS-A WIDER TOPIC 15 CHAPTER 4 STEM CELL RESEARCH 19 HISTORY 19 EMBRYONIC STEM CELLS 20 Growth and Identification of ESCs 20 Stimulating ESCs to Differentiate 21 NEW CELL LINE 21 ADULT STEM CELLS 22 Mesenchymal Stem Cells (MSCs) 22 Haematopoietic Stem Cells (HSCs) 23 Neural Stem Cells (NSCs) 23 Endothelial Progenitor Cells (EPCs) 23 Epithelial Stem Cells (ESCs) 23 Very Small Embryonic-Like Cells (VSELs) 23 CORD BLOOD STEM CELLS 23 INDUCED PLURIPOTENT STEM CELLS (IPSCS) 24 Nuclear Reprogramming 24 CELL-BASED THERAPEUTICS 25 EMBRYONIC-DERIVED STEM CELLS 25 ADULT/PROGENITOR-DERIVED STEM CELLS 26 ENGINEERED SCS FOR TRANSPLANTATION 26 THERAPEUTIC STEM CELL BANKING 27
The Global Market for Stem Cells (From Issuu)
Page 3/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! STEM CELL-BASED BIOMEDICAL RESEARCH 28 TABLE 1 STEM CELL RESEARCH CENTERS 28 REGULATION OF STEM CELL RESEARCH 30 AUSTRALIA 30 BRAZIL 31 CANADA 31 CHINA 31 FRANCE 31 GERMANY 32 INDIA 32 IRELAND 32 ISRAEL 33 ITALY 33 JAPAN 33 SOUTH KOREA 33 SPAIN 33 SWEDEN 34 UNITED KINGDOM 34 UNITED STATES 34 California 34 Massachusetts 35 Michigan 35 New Jersey 35 New York 35 FDA APPROACH 35 EUROPEAN UNION 35 PRACTICALITIES OF STEM CELL RESEARCH AND PRODUCTION 36 STEM CELL PRODUCTION 36 STEM CELL ACQUISITION 37 Characterization and Expansion 37 Maintenance and Storage 38 STEM CELL PRODUCTION ECONOMICS 39 Customized Therapy 39 Banks 40 NOVEL STEM CELL PRODUCTION DEVELOPMENTS 40 ISOLATION AND ENGINEERING 41 Adult Stem Cells 41 Embryonic Stem Cells 42 Induced Pluripotent Stem Cells 43 STEM CELL BANKING 44 ISCBI PROJECT 44 TABLE 2 COUNTRIES ENGAGED IN THE ISCBI PROGRAM 45 CHAPTER 5 STEM CELL APPLICATIONS 48 REGENERATIVE MEDICINE 48 CURRENT APPLICATIONS OF STEM CELL THERAPY 51 CANCER 51 Hematopoiesis (Blood Cell Formation) 51 AMYOTROPHIC LATERAL SCLEROSIS 52
The Global Market for Stem Cells (From Issuu)
Page 4/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! PARKINSON'S DISEASE 53 SPINAL CORD INJURY 54 ALZHEIMER'S DISEASE 56 STROKE 57 HEART DISEASE 59 Doubts Expressed 61 PERIPHERAL ARTERIAL DISEASE 61 TYPE 1 DIABETES 63 ORTHOPEDIC REPAIR 64 LIVER FAILURE 65 GRAFT-VERSUS-HOST DISEASE 66 LUNG DISEASE 67 STATUS OF STEM CELL CLINICAL TRIALS 67 Prochymal-stem Cell Therapy 68 Prochymal-Crohn's Disease and Gastrointestinal Injury from Radiation 68 Mesenchymal Precursor Cell (MPC) Product'Stem Cell Therapy (Orphan Drug) 68 MyoCell-Stem Cell Therapy 69 ixmyelocel-T-Stem Cell Therapy (Fast Track) 69 StemEx (carlecortemcel-L)'Stem Cell Therapy (Orphan Drug) (Fast Track) 69 GSK 2696273-Stem Cell Therapy 70 Adult Autologous Stem Cell Therapy (Renew)'Stem Cell Therapy 70 CHAPTER 6 STEM CELL PATENTS 73 GENERAL BACKGROUND ON PATENTS 73 STEM CELL PATENTS 74 PATENTABILITY OF STEM CELL LINES 74 INDIVIDUAL COUNTRY POLICIES 75 UNITED STATES 75 CANADA 75 EPC 75 UNITED KINGDOM 75 GERMANY 76 JAPAN 76 CHINA 76 iPS Cells 76 TABLE 3 IPS-RELATED PATENTS (YAMANAKA, 2011) 77 TABLE 4 CLASSIFICATION OF STEM CELL PATENTS 78 CHAPTER 7 STEM CELL MARKETS 80 MARKETS FOR STEM CELLS 80 MARKET DRIVERS 80 Healthcare 80 TABLE 5 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES 82 Biotechnology 83 Pharmaceutical 84 MARKET OPPORTUNITIES BY THERAPEUTIC CLASS 85 CANCER 85
The Global Market for Stem Cells (From Issuu)
Page 5/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Other Cancers 86 CARDIOVASCULAR DISEASE 86 Myocardial Infarction 88 TABLE 6 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD 89 CENTRAL NERVOUS SYSTEM DISEASE 89 Spinal Cord Injury (SCI) 90 TABLE 7 STATISTICS FOR SCI WORLDWIDE, 2011 90 Neurodegenerative Diseases 91 TABLE 8 NEURODEGENERATIVE DISEASES WORLDWIDE, 2011 (MILLIONS) 91 DIABETES MELLITUS 92 TABLE 9 STATISTICS FOR DIABETES IN THE U.S., 2014 92 TABLE 10 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES, THROUGH 2018 ($ BILLIONS) 93 SKELETAL SYSTEM 94 GLOBAL MARKET ESTIMATES AND FORECASTS 95 TABLE 11 GLOBAL STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 95 REGIONAL AND NATIONAL MARKET ANALYSIS 95 AMERICAS 95 TABLE 12 AMERICAS STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 95 U.S. 96 TABLE 13 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES 96 TABLE 14 THE U.S. STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 97 TABLE 15 THE U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 98 TABLE 16 THE U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 98 Canada 98 TABLE 17 CANADA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 99 TABLE 18 CANADA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 99 TABLE 19 CANADA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 100 Brazil 100 TABLE 20 BRAZIL'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 101 TABLE 21 BRAZIL'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 101 TABLE 22 BRAZIL'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 101 Mexico 102 TABLE 23 MEXICO'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 102 TABLE 24 MEXICO'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 102 EUROPE 103 TABLE 25 EUROPEAN STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 103 Market Opportunities by Disease Category 104 TABLE 26 STATISTICS FOR CVD IN EUROPE, 2012 104 TABLE 27 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES) 104
The Global Market for Stem Cells (From Issuu)
Page 6/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 28 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013 105 TABLE 29 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2011 105 TABLE 30 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN COUNTRIES, 2013 106 France 106 TABLE 31 FRANCE'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 106 TABLE 32 FRANCE'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 106 TABLE 33 FRANCE'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 107 Germany 107 TABLE 34 GERMANY'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 107 TABLE 35 GERMANY'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 108 TABLE 36 GERMANY'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 108 Italy 108 TABLE 37 ITALY'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 109 TABLE 38 ITALY'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 109 TABLE 39 ITALY'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 109 Spain 109 TABLE 40 SPAIN'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 111 TABLE 41 SPAIN'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 111 TABLE 42 SPAIN'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 111 United Kingdom 111 TABLE 43 U.K.'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 112 TABLE 44 U.K.'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 112 TABLE 45 U.K.'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 113 ASIA 113 Market Opportunities by Disease Category 113 TABLE 46 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011 113 TABLE 47 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES 114 TABLE 48 ASIA'S STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 114 Japan 114 TABLE 49 JAPAN'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 116 TABLE 50 JAPAN'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 116 TABLE 51 JAPAN'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 116 China 116 TABLE 52 CHINA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 119
The Global Market for Stem Cells (From Issuu)
Page 7/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 53 CHINA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 120 TABLE 54 CHINA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 120 India 120 TABLE 55 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA 121 TABLE 56 INDIA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 121 TABLE 57 INDIA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 122 TABLE 58 INDIA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 122 REST OF WORLD 122 TABLE 59 REST OF WORLD STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 122 CHAPTER 8 COMPANY PROFILES 124 3DM 125 AASTROM BIOSCIENCES INC. 125 ADVANCED CELL TECHNOLOGY INC. 126 ALDAGEN INC. 127 ANGIOBLAST SYSTEMS 127 ARTERIOCYTE 128 ATHERSYS INC. 128 BEIKE BIOTECHNOLOGY CO., LTD. 129 BIOHEART INC. 130 BIOTIME INC. 131 BRAINSTORM CELL THERAPEUTICS INC. 132 CAPRICOR INC. 133 CARDIO3 BIOSCIENCES S.A. 134 CELLARTIS AB 135 CELLERANT THERAPEUTICS INC. 136 CELLERIX SA 137 CELLULAR DYNAMICS INTERNATIONAL 138 CYTORI THERAPEUTICS INC. 138 EPISTEM LTD. 140 FORTICELL BIOSCIENCE INC. 140 GAMIDA CELL, LTD. 141 GLOBALSTEM 142 HYBRID ORGAN GMBH 143 INTELLICELL BIOSCIENCES INC. 143 INTERNATIONAL STEM CELL CORP. 144 JUVENTAS THERAPEUTICS INC. 145 MEDISTEM INC. 146 MESOBLAST LTD. 147 NEOSTEM INC. 148 NEURALSTEM 149 NEUROGENERATION 149 OSIRIS THERAPEUTICS INC. 150 PHARMASTEM THERAPEUTICS INC. 151 PLUREON CORP. 151
The Global Market for Stem Cells (From Issuu)
Page 8/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! PRIMEGEN BIOTECH LLC 151 RENEURON GROUP 152 RHINOCYTE INC. 153 STEM CELLS INC. 153 STEMCELL TECHNOLOGIES SARL 154 STEM CELL THERAPEUTICS CORP. 155 STEMEDICA CELL TECHNOLOGIES INC. 156 STEMINA BIOMARKER DISCOVERY INC. 156 STEMPEUTICS RESEARCH PVT. LTD. 157 TIGENIX NV 158 TRISTEM CORP. 159 VERASTEM INC. 160 VERISTEM TECHNOLOGIES 160 VIACYTE 161 VITRO DIAGNOSTICS INC. 162 WICELL RESEARCH INSTITUTE 162 XPAND BIOTECHNOLOGY BV 163 CHAPTER 9 APPENDIX 1: GLOSSARY 165 CHAPTER 10 APPENDIX 2: SIGNIFICANT STEM CELL RESEARCH PATENTS 172 TABLE 60 SIGNIFICANT STEM CELL RESEARCH PATENTS 172
LIST OF TABLES SUMMARY TABLE GLOBAL STEM CELL MARKET AND FORECASTS, THROUGH 2018 ($ MILLIONS) 8 TABLE 1 STEM CELL RESEARCH CENTERS 28 TABLE 2 COUNTRIES ENGAGED IN THE ISCBI PROGRAM 45 TABLE 3 IPS-RELATED PATENTS (YAMANAKA, 2011) 77 TABLE 4 CLASSIFICATION OF STEM CELL PATENTS 78 TABLE 5 HEALTHCARE SYSTEMS OF DIFFERENT COUNTRIES 82 TABLE 6 EXAMPLES OF COMPANIES DEVELOPING STEM CELL THERAPIES FOR CVD 89 TABLE 7 STATISTICS FOR SCI WORLDWIDE, 2011 90 TABLE 8 NEURODEGENERATIVE DISEASES WORLDWIDE, 2011 (MILLIONS) 91 TABLE 9 STATISTICS FOR DIABETES IN THE U.S., 2014 92 TABLE 10 GLOBAL MARKET FOR DIABETES MELLITUS TREATMENTS AND DEVICES, THROUGH 2018 ($ BILLIONS) 93 TABLE 11 GLOBAL STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 95 TABLE 12 AMERICAS STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 95 TABLE 13 POTENTIAL U.S. PATIENT POPULATIONS FOR CELL-BASED THERAPIES 96 TABLE 14 THE U.S. STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 97 TABLE 15 THE U.S. STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 98 TABLE 16 THE U.S. STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 98 TABLE 17 CANADA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 99 TABLE 18 CANADA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 99
The Global Market for Stem Cells (From Issuu)
Page 9/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 19 CANADA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 100 TABLE 20 BRAZIL'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 101 TABLE 21 BRAZIL'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 101 TABLE 22 BRAZIL'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 101 TABLE 23 MEXICO'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 102 TABLE 24 MEXICO'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 102 TABLE 25 EUROPEAN STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 103 TABLE 26 STATISTICS FOR CVD IN EUROPE, 2012 104 TABLE 27 RATE OF DEATH FROM HEART DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2012 (NO. OF DEATHS PER 100,000 CASES) 104 TABLE 28 STATISTICS FOR CNS DISORDERS AND INJURIES IN EUROPE, 2013 105 TABLE 29 STATISTICS FOR SCI AND PARKINSON'S DISEASE IN DIFFERENT EUROPEAN COUNTRIES, 2011 105 TABLE 30 PREVALENCE OF DIABETIC PATIENTS IN DIFFERENT EUROPEAN COUNTRIES, 2013 106 TABLE 31 FRANCE'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 106 TABLE 32 FRANCE'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 106 TABLE 33 FRANCE'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 107 TABLE 34 GERMANY'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 107 TABLE 35 GERMANY'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 108 TABLE 36 GERMANY'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 108 TABLE 37 ITALY'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 109 TABLE 38 ITALY'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 109 TABLE 39 ITALY'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 109 TABLE 40 SPAIN'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 111 TABLE 41 SPAIN'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 111 TABLE 42 SPAIN'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 111 TABLE 43 U.K.'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 112 TABLE 44 U.K.'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 112 TABLE 45 U.K.'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 113 TABLE 46 STATISTICS FOR CVD IN DIFFERENT REGIONS OF THE WORLD, 2011 113 TABLE 47 EXAMPLES OF STEM CELL POLICIES IN ASIAN COUNTRIES 114 TABLE 48 ASIA'S STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 114 TABLE 49 JAPAN'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 116
The Global Market for Stem Cells (From Issuu)
Page 10/13
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! TABLE 50 JAPAN'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 116 TABLE 51 JAPAN'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 116 TABLE 52 CHINA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 119 TABLE 53 CHINA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 120 TABLE 54 CHINA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 120 TABLE 55 POTENTIAL CANDIDATES FOR STEM CELL THERAPY IN INDIA 121 TABLE 56 INDIA'S STEM CELL THERAPY MARKET, THROUGH 2018 ($ MILLIONS) 121 TABLE 57 INDIA'S STEM CELL RESEARCH AND SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 122 TABLE 58 INDIA'S STEM CELL CORD BLOOD SERVICES MARKET, THROUGH 2018 ($ MILLIONS) 122 TABLE 59 REST OF WORLD STEM CELL MARKET, THROUGH 2018 ($ MILLIONS) 122 TABLE 60 SIGNIFICANT STEM CELL RESEARCH PATENTS 172
LIST OF FIGURES SUMMARY FIGURE GLOBAL STEM CELL MARKET AND FORECASTS, 2012-2018 ($ MILLIONS) 8 FIGURE 1 EARLY DEVELOPMENT OF EMBRYO 10
The Global Market for Stem Cells (From Issuu)
Page 11/13
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. The Global Market for Stem Cells
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 6 650.00
Quantity: _____
2-5 User License--USD 8 500.00
Quantity: _____
6-10 Users--USD 10 500.00
Quantity: _____
11-20 Users--USD 12 500.00
Quantity: _____
21+ Users--USD 15 000.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
The Global Market for Stem Cells (From Issuu)
Page 12/13
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
The Global Market for Stem Cells (From Issuu)
Asia, Oceania and America : + 1 (805) 617 17 93
Page 13/13